Assessment of low-density lipoprotein targets

Area of Science:

• Cardiology
• Lipidology
• Preventive Medicine

Background:

• The clinical significance of lowering total cholesterol and low-density lipoprotein cholesterol (LDL-C) to reduce cardiovascular (CV) risk has been established over many years.
• The Lipid Research Clinic study in 1984 provided significant early support for the lipid hypothesis, which has since been reinforced by numerous outcomes studies.

Purpose of the Study:

• To emphasize the continued importance of LDL-C reduction in cardiovascular disease (CV) prevention.
• To address the premature advocacy by some to abandon LDL-C reduction as a therapeutic target.
• To highlight that LDL-C reduction strategies do not impede the understanding of atherosclerosis complexities or new CV prevention approaches.

Main Methods:

• Review of historical lipid hypothesis support, including the Lipid Research Clinic study.
• Analysis of multiple subsequent outcomes studies validating LDL-C reduction for CV risk decrease.
• Consideration of other CV risk factors (inflammation, endothelial dysfunction) and medication effects (statins).

Main Results:

• Decades of research and multiple studies confirm the value of LDL-C reduction in decreasing CV risk.
• LDL-C reduction is widely accepted by clinicians as a primary guideline for CV disease prevention.
• Despite established value, challenges with clinician adherence to CV risk modification persist.

Conclusions:

• Abandoning LDL-C reduction as a target is premature and contraindicated, given its well-established benefits.
• Continued focus on LDL-C reduction is essential for effective cardiovascular disease prevention.
• Understanding atherosclerosis complexity and exploring new approaches can complement, not replace, LDL-C reduction strategies.